Author:
Pratama Muhammad Yogi,Cavalletto Luisa,Tiribelli Claudio,Chemello Liliana,Pascut Devis
Abstract
AbstractNormalization procedures for the qRT-PCR analysis of miRNA in biological samples are recommended to reduce the variability caused by pre-analytical factors. Since there is no universal standardized normalization strategy for miRNA qRT-PCR studies, we conducted a throughout study to evaluate a panel of small non-coding RNAs (sncRNAs) as reference gene candidate for biomarker studies in serum samples of patients with hepatocellular carcinoma (HCC). Five sncRNAs (miR-1280, miR-1275, SNORD-116, SNORD-68, and U6) were chosen as candidate of reference genes. This study included 122 patients with HCC and was organized into a “pilot phase” consisting of 20 serum samples of HCC patients, and a “validation phase” of 102 patients. Expression level of these candidates were analyzed by qRT-PCR. Assessment of gene stability was performed using four different integrative platforms (geNorm NormFinder, Bestkeeper, and the Delta Ct method). To determine the gene stability during the follow-up of the patient, we extend the analysis of the validation cohort at T1 (1 month after treatment) and T2 (6 month after treatment). MiR-1280 was identified as the most stably expressed reference gene in both pilot and validation phase also during the follow-up. MiR-1280 appears a reliable reference gene candidate in biomarker studies.
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Bray, F. et al. Global cancer statistics: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin. 0 (2018).
2. Aggarwal, M., Arain, A. & Jin, Z. Systemic treatment for hepatocellular carcinoma. Chronic Dis. Transl. Med. 4, 148–155 (2018).
3. Iñarrairaegui, M., Melero, I. & Sangro, B. Immunotherapy of Hepatocellular Carcinoma: Facts and Hopes. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 24, 1518–1524 (2018).
4. Le Grazie, M., Biagini, M. R., Tarocchi, M., Polvani, S. & Galli, A. Chemotherapy for hepatocellular carcinoma: The present and the future. World J. Hepatol. 9, 907–920 (2017).
5. Amr, K. S. et al. The potential role of miRNAs 21 and 199-a in early diagnosis of hepatocellular carcinoma. Gene 575, 66–70 (2016).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献